Kenichi Fukushima
Matsudo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Prognostic impact of chronic kidney disease in patients with atrial fibrillation after percutaneous coronary intervention.
Journal: Journal of cardiology
Published: August 07, 2025
Impact of Underdosing of Direct Oral Anticoagulants on Clinical Outcomes in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.
Journal: Circulation journal : official journal of the Japanese Circulation Society
Published: December 22, 2024
Relationship between body mass index and clinical events in patients with atrial fibrillation undergoing percutaneous coronary intervention.
Journal: PloS one
Published: June 01, 2024
Prognosis of anemic patients with atrial fibrillation undergoing percutaneous coronary intervention.
Prognosis of anemic patients with atrial fibrillation undergoing percutaneous coronary intervention.
Journal: International journal of cardiology
Published: January 28, 2024
Peripartum cardiomyopathy in patients with psychiatric disorders successfully treated with bromocriptine: Two case reports.
Journal: Journal of cardiology cases
Published: September 07, 2023
Dual antithrombotic therapy with oral anticoagulant and P2Y12 inhibitors in patients with atrial fibrillation after percutaneous coronary intervention.
Journal: Journal of cardiology
Published: February 13, 2023
Impact of Renal Function on Anti-factor Xa Activity Concentrations with Edoxaban Use in Patients with Non-valvular Atrial Fibrillation.
Journal: Drugs in R&D
Published: August 16, 2022
Anti-factor Xa activity, prothrombin time, and activated partial thromboplastin time in patients treated with factor Xa inhibitors.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: July 06, 2022
Implantable cardioverter-defibrillator therapy after resuscitation from cardiac arrest in vasospastic angina: A retrospective study.
Journal: PloS one
Published: June 15, 2022
Nivolumab-induced Myositis and Myocarditis with Positive Anti-titin Antibody and Anti-voltage-gated Potassium Channel Kv1.4 Antibody.
Journal: Internal medicine (Tokyo, Japan)
Published: March 22, 2022
Coagulation markers in patients with venous thromboembolism treated with 10 mg apixaban twice daily.
Coagulation markers in patients with venous thromboembolism treated with 10 mg apixaban twice daily.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: October 30, 2021
Last Updated: 09/26/2026